Mustang Bio, Inc. (MBIO)
0.5412
0.00 (0.00%)
USD |
NASDAQ |
Sep 08, 16:00
Mustang Bio Market Cap : 4.101M for Sept. 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 4.101M |
| September 04, 2026 | 4.114M |
| September 03, 2026 | 4.243M |
| September 02, 2026 | 4.115M |
| September 01, 2026 | 4.153M |
| August 31, 2026 | 4.073M |
| August 28, 2026 | 4.074M |
| August 27, 2026 | 4.168M |
| August 26, 2026 | 4.243M |
| August 25, 2026 | 4.183M |
| August 24, 2026 | 4.178M |
| August 21, 2026 | 4.385M |
| August 20, 2026 | 4.341M |
| August 19, 2026 | 4.350M |
| August 18, 2026 | 4.319M |
| August 17, 2026 | 4.503M |
| August 14, 2026 | 4.497M |
| August 13, 2026 | 4.501M |
| August 12, 2026 | 4.587M |
| August 11, 2026 | 4.607M |
| August 10, 2026 | 4.472M |
| August 07, 2026 | 4.552M |
| August 06, 2026 | 4.359M |
| August 05, 2026 | 4.523M |
| August 04, 2026 | 4.501M |
| Date | Value |
|---|---|
| August 03, 2026 | 4.369M |
| July 31, 2026 | 4.321M |
| July 30, 2026 | 4.500M |
| July 29, 2026 | 4.395M |
| July 28, 2026 | 4.784M |
| July 27, 2026 | 4.243M |
| July 24, 2026 | 4.259M |
| July 23, 2026 | 4.320M |
| July 22, 2026 | 4.478M |
| July 21, 2026 | 4.666M |
| July 20, 2026 | 4.940M |
| July 17, 2026 | 4.760M |
| July 16, 2026 | 4.884M |
| July 15, 2026 | 4.789M |
| July 14, 2026 | 5.019M |
| July 13, 2026 | 5.030M |
| July 10, 2026 | 5.332M |
| July 09, 2026 | 5.607M |
| July 08, 2026 | 5.151M |
| July 07, 2026 | 5.378M |
| July 06, 2026 | 5.378M |
| July 02, 2026 | 5.327M |
| July 01, 2026 | 5.314M |
| June 30, 2026 | 5.319M |
| June 29, 2026 | 5.301M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.780B |
| Alnylam Pharmaceuticals, Inc. | 33.98B |
| Anika Therapeutics, Inc. | 280.78M |
| Savara, Inc. | 1.111B |
| Vericel Corp. | 1.985B |
Market Cap Related Metrics
| Price to Book Value | 0.5435 |
| Price | 0.5412 |
| Earnings Yield | -83.11% |